Dr Cynthia A Nater Tzilianos, MD | |
1279 Highway 54 W, Suite 220, Fayetteville, GA 30214-4552 | |
(770) 991-2200 | |
(770) 991-1341 |
Full Name | Dr Cynthia A Nater Tzilianos |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 1279 Highway 54 W, Fayetteville, Georgia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679584072 | NPI | - | NPPES |
501518174A | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 056200 (Georgia) | Primary |
Entity Name | Dhp Of Piedmont Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316202609 PECOS PAC ID: 9133378763 Enrollment ID: O20120925000798 |
News Archive
A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company support the American Diabetes Association call for an independent review of the safety data of incretin-based therapies.
Cholesterol gets lots of bad press, and for good reason. An estimated 24 million women and 18 million men have total cholesterol levels of 240 milligrams per deciliter (mg/dL) or higher increasing their risk of heart attack and stroke.
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
› Verified 7 days ago
Entity Name | Georgia Ob-gyn Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295440949 PECOS PAC ID: 9032578927 Enrollment ID: O20230711000546 |
News Archive
A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company support the American Diabetes Association call for an independent review of the safety data of incretin-based therapies.
Cholesterol gets lots of bad press, and for good reason. An estimated 24 million women and 18 million men have total cholesterol levels of 240 milligrams per deciliter (mg/dL) or higher increasing their risk of heart attack and stroke.
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cynthia A Nater Tzilianos, MD 1279 Highway 54 West, Suite 220, Fayetteville, GA 30214-4552 Ph: (770) 991-2200 | Dr Cynthia A Nater Tzilianos, MD 1279 Highway 54 W, Suite 220, Fayetteville, GA 30214-4552 Ph: (770) 991-2200 |
News Archive
A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company support the American Diabetes Association call for an independent review of the safety data of incretin-based therapies.
Cholesterol gets lots of bad press, and for good reason. An estimated 24 million women and 18 million men have total cholesterol levels of 240 milligrams per deciliter (mg/dL) or higher increasing their risk of heart attack and stroke.
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has approved its New Drug Application for Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% as a treatment for acute herpetic keratitis (dendritic ulcers). The FDA granted orphan drug designation to Zirgan for this indication in April 2007.
› Verified 7 days ago
Tanya Denise Beckford, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1279 Highway 54 W, Suite 220, Fayetteville, GA 30214 Phone: 770-991-2200 Fax: 770-716-8672 | |
Dr. Crystal O Slade, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1279 Highway 54 W, Suite 220, Fayetteville, GA 30214 Phone: 770-991-2200 Fax: 770-991-1341 | |
Dr. Thomas K Taylor, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 125 Astaire Mnr, Fayetteville, GA 30214 Phone: 404-661-8858 | |
Matthew M Ralsten, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1267 Highway 54 West, Suite 3200, Fayetteville, GA 30214 Phone: 770-632-9900 Fax: 770-632-9997 | |
Dr. Benita L Bonser, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1279 Highway 54 W, Suite 220, Fayetteville, GA 30214 Phone: 770-991-2200 Fax: 770-991-1341 | |
Dr. Judonn Theophilous Adams, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 120 Carnegie Pl, Suite 104, Fayetteville, GA 30214 Phone: 770-460-5667 Fax: 770-460-6710 | |
Dr. Edwin Bello, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1279 Highway 54 W, Suite 220, Fayetteville, GA 30214 Phone: 770-991-2200 Fax: 770-991-1341 |